Farallon Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Hold |
|
|||||
|
2025
Q1 | $159K | Hold |
|
|||||
|
2024
Q4 | $247K | Hold |
|
|||||
|
2024
Q3 | $230K | Hold |
|
|||||
|
2024
Q2 | $185K | Sell |
|
|||||
|
2024
Q1 | $14.1M | Sell |
|
|||||
|
2023
Q4 | $60.7M | Sell |
|
|||||
|
2023
Q3 | $85.4M | Buy |
|
|||||
|
2023
Q2 | $111M | Buy |
|
|||||
|
2023
Q1 | $73.6M | Buy |
|
|||||
|
2022
Q4 | $32.8M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $14.8M | Sell |
|
|||||
|
2021
Q4 | $41.9M | Buy |
|
|||||
|
2021
Q3 | $50.9M | Buy |
|
|||||
|
2021
Q2 | $8.74M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $54.5M | Sell |
|
|||||
|
2020
Q3 | $40.1M | Buy |
|
|||||
|
2020
Q2 | $10.3M | Hold |
|
|||||
|
2020
Q1 | $9.18M | Hold |
|
|||||
|
2019
Q4 | $15.4M | Buy |
|